HYALURONIDASE 150 [USP'U]/mL
HYALURONIDASE · INJECTION, SOLUTION · HF Acquisition Co LLC, DBA HealthFirst
No Recall History
Plain English
HYALURONIDASE is a injection, solution containing hyaluronidase at 150 [USP'U]/mL, taken subcutaneous. Manufactured by HF Acquisition Co LLC, DBA HealthFirst.
Key Facts
- Brand Name
- HYALURONIDASE
- Generic Name
- HYALURONIDASE
- NDC Code (Product)
51662-1555- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Strength
- 150 [USP'U]/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA021859
- Drug Class
- Endoglycosidase [EPC]
- Marketing Start
- 06/04/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is HYALURONIDASE used for?
HYALURONIDASE contains HYALURONIDASE. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is HYALURONIDASE a controlled substance?
HYALURONIDASE is not classified as a controlled substance by the DEA.
What is the generic name for HYALURONIDASE?
The generic name for HYALURONIDASE is HYALURONIDASE. There are 2 other brand versions of HYALURONIDASE.
What is the NDC code for HYALURONIDASE 150 [USP'U]/mL?
The NDC (National Drug Code) for HYALURONIDASE 150 [USP'U]/mL is 51662-1555, listed by HF Acquisition Co LLC, DBA HealthFirst.